Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 404

1.

miRNAs involvement in the pathogenesis of Richter's syndrome.

Van Roosbroeck K, Bayraktar R, Calin S, Bloehdorn J, Dragomir MP, Okubo K, Bertilaccio MTS, Zupo S, You MJ, Gaidano G, Rossi D, Chen SS, Chiorazzi N, Thompson P, Ferrajoli A, Bertoni F, Stilgenbauer S, Keating MJ, Calin GA.

Haematologica. 2018 Nov 8. pii: haematol.2018.203828. doi: 10.3324/haematol.2018.203828. [Epub ahead of print]

2.

Correction: CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer.

Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, Croce CM, Calin GA, Esteller M.

Oncogene. 2018 Nov 5. doi: 10.1038/s41388-018-0560-1. [Epub ahead of print]

PMID:
30397238
3.

Long non-coding RNA CCAT2 as a therapeutic target in colorectal cancer.

Foßelteder J, Calin GA, Pichler M.

Expert Opin Ther Targets. 2018 Dec;22(12):973-976. doi: 10.1080/14728222.2018.1541453. Epub 2018 Oct 30. No abstract available.

PMID:
30365347
4.

Measurement of miRNAs in Chronic Lymphocytic Leukemia Patient Samples by Quantitative Reverse Transcription PCR.

Van Roosbroeck K, Bayraktar R, Calin GA.

Methods Mol Biol. 2019;1881:267-276. doi: 10.1007/978-1-4939-8876-1_20.

PMID:
30350212
5.

miR-122 and hepatocellular carcinoma: from molecular biology to therapeutics.

Fu X, Calin GA.

EBioMedicine. 2018 Oct 15. pii: S2352-3964(18)30450-X. doi: 10.1016/j.ebiom.2018.10.032. [Epub ahead of print] No abstract available.

6.

Corrigendum: Circular RNAs in Cancer - Lessons Learned From microRNAs.

Dragomir M, Calin GA.

Front Oncol. 2018 Sep 21;8:307. doi: 10.3389/fonc.2018.00307. eCollection 2018.

7.

CpG island hypermethylation go circular (RNA).

Dragomir MP, Calin GA.

Oncotarget. 2018 Sep 4;9(69):33052-33053. doi: 10.18632/oncotarget.26074. eCollection 2018 Sep 4. No abstract available.

8.

The Non-Coding RNA Journal Club: Highlights on Recent Papers-6.

Xiao H, Shiu PKT, Shu J, Santulli G, Gheybi MK, Conn SJ, Bogard B, Hubé F, Taube JH, Mani SA, Song L, Calin GA, Zhang S.

Noncoding RNA. 2018 Sep 18;4(3). pii: E23. doi: 10.3390/ncrna4030023.

9.

Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK1-eIF4G-eIF4E signaling.

Shen P, Reineke LC, Knutsen E, Chen M, Pichler M, Ling H, Calin GA.

Mol Oncol. 2018 Nov;12(11):1856-1870. doi: 10.1002/1878-0261.12384. Epub 2018 Oct 15.

10.

New Definitions of Sepsis and the Quest for Specific Biomarkers. Are the miRNAs the Answer?

Manga G, Calin GA, Manuc M, Droc G, Tudor S.

Chirurgia (Bucur). 2018 Jul-Aug;113(4):464-468. doi: 10.21614/chirurgia.113.4.464.

11.

OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers.

Monroig-Bosque PDC, Shah MY, Fu X, Fuentes-Mattei E, Ling H, Ivan C, Nouraee N, Huang B, Chen L, Pileczki V, Redis RS, Jung EJ, Zhang X, Lehrer M, Nagvekar R, Mafra ACP, Monroig-Bosque MDM, Irimie A, Rivera C, Dan Dumitru C, Berindan-Neagoe I, Nikonowicz EP, Zhang S, Calin GA.

Sci Rep. 2018 Aug 30;8(1):13106. doi: 10.1038/s41598-018-30989-3.

12.

Exosomal lncRNAs as new players in cell-to-cell communication.

Dragomir M, Chen B, Calin GA.

Transl Cancer Res. 2018 Mar;7(Suppl 2):S243-S252. doi: 10.21037/tcr.2017.10.46.

13.

MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance.

Iqbal MA, Arora S, Prakasam G, Calin GA, Syed MA.

Mol Aspects Med. 2018 Aug 17. pii: S0098-2997(18)30065-7. doi: 10.1016/j.mam.2018.07.003. [Epub ahead of print] Review.

PMID:
30102929
14.

SnapShot: Unconventional miRNA Functions.

Dragomir MP, Knutsen E, Calin GA.

Cell. 2018 Aug 9;174(4):1038-1038.e1. doi: 10.1016/j.cell.2018.07.040.

PMID:
30096304
15.

Profiling the circulating miRnome reveals a temporal regulation of the bone injury response.

Silva AM, Almeida MI, Teixeira JH, Ivan C, Oliveira J, Vasconcelos D, Neves N, Ribeiro-Machado C, Cunha C, Barbosa MA, Calin GA, Santos SG.

Theranostics. 2018 Jun 24;8(14):3902-3917. doi: 10.7150/thno.24444. eCollection 2018.

16.

Epigenetics of gastrointestinal diseases: notes from a workshop.

Marks DL, Olson RL, Urrutia R, Billadeau DD, Roy N, Calin GA, Fabbri M, Koutsioumpa M, Iliopoulos D, Ordog T, Huebert R, Sarmento O, Bamidele AO, Faubion W, Lomberk GL, Siveke J, Ahuja N, Iovanna J, Hlady RA, Robertson K, Kisiel J, Pin CL, Fernandez-Zapico ME.

Epigenetics. 2018;13(4):449-457. doi: 10.1080/15592294.2018.1464351. Epub 2018 Jul 30.

17.

MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways.

Malpeli G, Barbi S, Tosadori G, Greco C, Zupo S, Pedron S, Brunelli M, Bertolaso A, Scupoli MT, Krampera M, Kamga PT, Croce CM, Calin GA, Scarpa A, Zamò A.

Oncotarget. 2018 Jul 3;9(51):29753-29771. doi: 10.18632/oncotarget.25707. eCollection 2018 Jul 3.

18.

Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways.

Abruzzo LV, Herling CD, Calin GA, Oakes C, Barron LL, Banks HE, Katju V, Keating MJ, Coombes KR.

Haematologica. 2018 Jul 5. pii: haematol.2018.190132. doi: 10.3324/haematol.2018.190132. [Epub ahead of print]

19.

Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.

Kabil N, Bayraktar R, Kahraman N, Mokhlis HA, Calin GA, Lopez-Berestein G, Ozpolat B.

Breast Cancer Res Treat. 2018 Oct;171(3):593-605. doi: 10.1007/s10549-018-4847-2. Epub 2018 Jul 3.

PMID:
29971628
20.

Key questions about the checkpoint blockade-are microRNAs an answer?

Dragomir M, Chen B, Fu X, Calin GA.

Cancer Biol Med. 2018 May;15(2):103-115. doi: 10.20892/j.issn.2095-3941.2018.0006.

21.

Using microRNA Networks to Understand Cancer.

Dragomir M, Mafra ACP, Dias SMG, Vasilescu C, Calin GA.

Int J Mol Sci. 2018 Jun 26;19(7). pii: E1871. doi: 10.3390/ijms19071871. Review.

22.

Circular RNAs in Cancer - Lessons Learned From microRNAs.

Dragomir M, Calin GA.

Front Oncol. 2018 May 28;8:179. doi: 10.3389/fonc.2018.00179. eCollection 2018. Review. Erratum in: Front Oncol. 2018 Sep 21;8:307.

23.

Clinical utility of circulating non-coding RNAs - an update.

Anfossi S, Babayan A, Pantel K, Calin GA.

Nat Rev Clin Oncol. 2018 Sep;15(9):541-563. doi: 10.1038/s41571-018-0035-x. Review.

PMID:
29784926
24.

MicroRNAs, Regulatory Messengers Inside and Outside Cancer Cells.

Anfossi S, Fu X, Nagvekar R, Calin GA.

Adv Exp Med Biol. 2018;1056:87-108. doi: 10.1007/978-3-319-74470-4_6. Review.

PMID:
29754176
25.

Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion.

Bayraktar R, Ivan C, Bayraktar E, Kanlikilicer P, Kabil NN, Kahraman N, Mokhlis HA, Karakas D, Rodriguez-Aguayo C, Arslan A, Sheng J, Wong S, Lopez-Berestein G, Calin GA, Ozpolat B.

Clin Cancer Res. 2018 Sep 1;24(17):4225-4241. doi: 10.1158/1078-0432.CCR-17-1959. Epub 2018 May 10.

PMID:
29748184
26.

Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion.

Chaganty BKR, Qiu S, Gest A, Lu Y, Ivan C, Calin GA, Weiner LM, Fan Z.

Cancer Lett. 2018 Aug 28;430:47-56. doi: 10.1016/j.canlet.2018.05.009. Epub 2018 May 8.

PMID:
29746929
27.

Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations.

Shah MY, Ferracin M, Pileczki V, Chen B, Redis R, Fabris L, Zhang X, Ivan C, Shimizu M, Rodriguez-Aguayo C, Dragomir M, Van Roosbroeck K, Almeida MI, Ciccone M, Nedelcu D, Cortez MA, Manshouri T, Calin S, Muftuoglu M, Banerjee PP, Badiwi MH, Parker-Thornburg J, Multani A, Welsh JW, Estecio MR, Ling H, Tomuleasa C, Dima D, Yang H, Alvarez H, You MJ, Radovich M, Shpall E, Fabbri M, Rezvani K, Girnita L, Berindan-Neagoe I, Maitra A, Verstovsek S, Fodde R, Bueso-Ramos C, Gagea M, Manero GG, Calin GA.

Genome Res. 2018 Apr;28(4):432-447. doi: 10.1101/gr.225128.117. Epub 2018 Mar 22.

28.

Hematopoietic stem cells from induced pluripotent stem cells - considering the role of microRNA as a cell differentiation regulator.

Ferreira AF, Calin GA, Picanço-Castro V, Kashima S, Covas DT, de Castro FA.

J Cell Sci. 2018 Feb 21;131(4). pii: jcs203018. doi: 10.1242/jcs.203018. Review.

29.

Crucial role of non-coding RNAs in disease.

Peng Y, Calin GA.

Cancer Lett. 2018 Apr 28;420:127-128. doi: 10.1016/j.canlet.2018.02.001. Epub 2018 Feb 6. No abstract available.

PMID:
29425682
30.

Featuring the special issue Guest Editor.

Calin GA.

Cancer Lett. 2018 Jun 1;423:27. doi: 10.1016/j.canlet.2018.01.004. Epub 2018 Jan 9. No abstract available.

PMID:
29330106
31.

MiR-181 family-specific behavior in different cancers: a meta-analysis view.

Pop-Bica C, Pintea S, Cojocneanu-Petric R, Del Sal G, Piazza S, Wu ZH, Alencar AJ, Lossos IS, Berindan-Neagoe I, Calin GA.

Cancer Metastasis Rev. 2018 Mar;37(1):17-32. doi: 10.1007/s10555-017-9714-9.

PMID:
29327093
32.

Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.

Vannini I, Wise PM, Challagundla KB, Plousiou M, Raffini M, Bandini E, Fanini F, Paliaga G, Crawford M, Ferracin M, Ivan C, Fabris L, Davuluri RV, Guo Z, Cortez MA, Zhang X, Chen L, Zhang S, Fernandez-Cymering C, Han L, Carloni S, Salvi S, Ling H, Murtadha M, Neviani P, Gitlitz BJ, Laird-Offringa IA, Nana-Sinkam P, Negrini M, Liang H, Amadori D, Cimmino A, Calin GA, Fabbri M.

Nat Commun. 2018 Jan 8;9(1):160. doi: 10.1038/s41467-017-02485-1.

33.

Preface.

Calin GA, Van Roosbroeck K.

Cancer Metastasis Rev. 2018 Mar;37(1):3-4. doi: 10.1007/s10555-017-9722-9. No abstract available.

PMID:
29285656
34.

Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.

Vannini I, Wise PM, Challagundla KB, Plousiou M, Raffini M, Bandini E, Fanini F, Paliaga G, Crawford M, Ferracin M, Ivan C, Fabris L, Davuluri RV, Guo Z, Cortez MA, Zhang X, Chen L, Zhang S, Fernandez-Cymering C, Han L, Carloni S, Salvi S, Ling H, Murtadha M, Neviani P, Gitlitz BJ, Laird-Offringa IA, Nana-Sinkam P, Negrini M, Liang H, Amadori D, Cimmino A, Calin GA, Fabbri M.

Nat Commun. 2017 Nov 27;8(1):1801. doi: 10.1038/s41467-017-01562-9. Erratum in: Nat Commun. 2018 Jan 8;9(1):160.

35.

miR-195 inhibits macrophages pro-inflammatory profile and impacts the crosstalk with smooth muscle cells.

Bras JP, Silva AM, Calin GA, Barbosa MA, Santos SG, Almeida MI.

PLoS One. 2017 Nov 22;12(11):e0188530. doi: 10.1371/journal.pone.0188530. eCollection 2017.

36.

Roles and clinical implications of microRNAs in acute lymphoblastic leukemia.

Ultimo S, Martelli AM, Zauli G, Vitale M, Calin GA, Neri LM.

J Cell Physiol. 2018 Aug;233(8):5642-5654. doi: 10.1002/jcp.26290. Epub 2018 Feb 28. Review.

PMID:
29154447
37.

A total transcriptome profiling method for plasma-derived extracellular vesicles: applications for liquid biopsies.

Amorim MG, Valieris R, Drummond RD, Pizzi MP, Freitas VM, Sinigaglia-Coimbra R, Calin GA, Pasqualini R, Arap W, Silva IT, Dias-Neto E, Nunes DN.

Sci Rep. 2017 Oct 31;7(1):14395. doi: 10.1038/s41598-017-14264-5.

38.

TRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p.

Berrout J, Kyriakopoulou E, Moparthi L, Hogea AS, Berrout L, Ivan C, Lorger M, Boyle J, Peers C, Muench S, Gomez JE, Hu X, Hurst C, Hall T, Umamaheswaran S, Wesley L, Gagea M, Shires M, Manfield I, Knowles MA, Davies S, Suhling K, Gonzalez YT, Carragher N, Macleod K, Abbott NJ, Calin GA, Gamper N, Zygmunt PM, Timsah Z.

Nat Commun. 2017 Oct 16;8(1):947. doi: 10.1038/s41467-017-00983-w.

39.

Cell-to-cell communication: microRNAs as hormones.

Bayraktar R, Van Roosbroeck K, Calin GA.

Mol Oncol. 2017 Dec;11(12):1673-1686. doi: 10.1002/1878-0261.12144. Epub 2017 Oct 26. Review.

40.

To Wnt or Lose: The Missing Non-Coding Linc in Colorectal Cancer.

Shen P, Pichler M, Chen M, Calin GA, Ling H.

Int J Mol Sci. 2017 Sep 20;18(9). pii: E2003. doi: 10.3390/ijms18092003. Review.

41.

Serum HOTAIR and GAS5 levels as predictors of survival in patients with glioblastoma.

Shen J, Hodges TR, Song R, Gong Y, Calin GA, Heimberger AB, Zhao H.

Mol Carcinog. 2018 Jan;57(1):137-141. doi: 10.1002/mc.22739. Epub 2017 Oct 10.

PMID:
28926136
42.

The role of a new class of long noncoding RNAs transcribed from ultraconserved regions in cancer.

Terracciano D, Terreri S, de Nigris F, Costa V, Calin GA, Cimmino A.

Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):449-455. doi: 10.1016/j.bbcan.2017.09.001. Epub 2017 Sep 13. Review.

PMID:
28916343
43.

Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer.

Bellido F, Sowada N, Mur P, Lázaro C, Pons T, Valdés-Mas R, Pineda M, Aiza G, Iglesias S, Soto JL, Urioste M, Caldés T, Balbín M, Blay P, Rueda D, Durán M, Valencia A, Moreno V, Brunet J, Blanco I, Navarro M, Calin GA, Borck G, Puente XS, Capellá G, Valle L.

Gastroenterology. 2018 Jan;154(1):181-194.e20. doi: 10.1053/j.gastro.2017.09.005. Epub 2017 Sep 12.

PMID:
28912018
44.

Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer.

Rodriguez-Aguayo C, Monroig PDC, Redis RS, Bayraktar E, Almeida MI, Ivan C, Fuentes-Mattei E, Rashed MH, Chavez-Reyes A, Ozpolat B, Mitra R, Sood AK, Calin GA, Lopez-Berestein G.

Cell Discov. 2017 Sep 12;3:17029. doi: 10.1038/celldisc.2017.29. eCollection 2017.

45.

Cancer Hallmarks and MicroRNAs: The Therapeutic Connection.

Van Roosbroeck K, Calin GA.

Adv Cancer Res. 2017;135:119-149. doi: 10.1016/bs.acr.2017.06.002. Epub 2017 Aug 12. Review.

PMID:
28882220
46.

Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587.

Figueroa J, Phillips LM, Shahar T, Hossain A, Gumin J, Kim H, Bean AJ, Calin GA, Fueyo J, Walters ET, Kalluri R, Verhaak RG, Lang FF.

Cancer Res. 2017 Nov 1;77(21):5808-5819. doi: 10.1158/0008-5472.CAN-16-2524. Epub 2017 Aug 30.

47.

Circulating miRNAs in sepsis-A network under attack: An in-silico prediction of the potential existence of miRNA sponges in sepsis.

Vasilescu C, Dragomir M, Tanase M, Giza D, Purnichescu-Purtan R, Chen M, Yeung SJ, Calin GA.

PLoS One. 2017 Aug 18;12(8):e0183334. doi: 10.1371/journal.pone.0183334. eCollection 2017.

48.

The Many Faces of Long Noncoding RNAs in Cancer.

Wu X, Tudoran OM, Calin GA, Ivan M.

Antioxid Redox Signal. 2018 Sep 20;29(9):922-935. doi: 10.1089/ars.2017.7293. Epub 2017 Oct 20.

49.

Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model.

D'Abundo L, Callegari E, Bresin A, Chillemi A, Elamin BK, Guerriero P, Huang X, Saccenti E, Hussein EMAA, Casciano F, Secchiero P, Zauli G, Calin GA, Russo G, Lee LJ, Croce CM, Marcucci G, Sabbioni S, Malavasi F, Negrini M.

Oncogene. 2017 Nov 23;36(47):6617-6626. doi: 10.1038/onc.2017.269. Epub 2017 Aug 7.

50.

Understanding the Genomic Ultraconservations: T-UCRs and Cancer.

Fabris L, Calin GA.

Int Rev Cell Mol Biol. 2017;333:159-172. doi: 10.1016/bs.ircmb.2017.04.004. Epub 2017 Jun 7. Review.

PMID:
28729024

Supplemental Content

Loading ...
Support Center